When you buy through links on our site , we may gain an affiliate commission . Here ’s how it works .
On a hot Saturday in San Antonio over 10 class ago , an 8 - twelvemonth - old boy was rushed to the hospital after days of fever , vexation , vomiting and sensitivity to light . The child ’s female parent , who last near the Texas - Mexico border , had taken him to a series of clinic in Mexico , but his condition had worsened . The child was now unconscious and unresponsive to sound , spark or other input .
Dr. put the child on a breathing apparatus and began a breakneck endeavor to find out what was wrong . What they discovered , swim in the son ’s cerebrospinal fluid , was an organism that left picayune way for hope : Naegleria fowleri , more popularly known as a " brain - eating amoeba . "
New drugs may help patients with life-threatening “brain-eating” amoeba infections.
It was the third case thatDr . Dennis Conrad , a pediatric infective disease specialist , then at University Hospital in San Antonio , had ever regard in his career . The other two patients had pall .
But Conrad had of late scan that a new drug option , miltefosine , had been approved as an experimental intervention forN. fowleriinfections . He added it to the boy ’s drug regimen , which already include other antimicrobic and anti - rabble-rousing medications .
" It ’s the kitchen sump , " Conrad told Live Science . " It ’s a unfit disease , and you just strike them with everything you could think of . "
A image ofN. fowleriunder the microscope.
The child ’s prognosis was disconsolate . He hadbeen disgusted for five daysbefore arriving in San Antonio , and most multitude who squeeze an infection withN. fowleridieabout five days after symptoms pop . According to the Centers for Disease Control and Prevention ( CDC ) , there were 157 affirm human cases ofN. fowleriinfection in the United States between 1962 and 2022 . Four survive .
Elsewhere in the world , the numbers are similar . It ’s rare to become ill from an infection with this amoeba — and it ’s very , very rarefied to endure . But the few recent survivors may owe their recuperation to miltefosine , the most recently recommended raw medication for elementary amebic cerebromeningitis ( PAM ) , the disease make by the ameba . novel drugs may be on the horizon as well . The interrogative sentence is whether they can reach patients before the terms is done .
‘A bull in a china shop’
N. fowlerithrives in warm fresh piddle around 80 degrees Fahrenheit ( 26.6 degree Anders Celsius ) or warm , although it might manage to give ear on in cool temperatures , too , harmonize to theCDC . It infects citizenry purely by stroke , when water is forced up the nozzle , driving the amoeba through a lacy bone call the cribriform plate to the olfactory face , which roleplay as a highway to the Einstein .
Immunocompromised people are at higher risk , saidDr . Juan Fernando Ortiz , a clinical neurology resident at Corewell Health in Grand Rapids , Michigan , who wrote ajournal clause about handle the transmission . Boys under old age 14 make up a disproportionate issue of case , consort to the CDC , perhaps because they ’re more potential than other group to do things that push water up the nose , like jump and diving . Most cases take natural bodies of piss , but cases have seldom been relate to treated water , such as in splash pad . In a few fount , people have induce infect by using pat water in neti jackpot to rinse off their sinuses .
Thechild Conrad and his colleagues were treatingin August of 2013 had a tragically distinctive story of contagion . He had spent the summer with his female parent at an informal camp on the bank of the Rio Grande , where there was no course body of water . the great unwashed bathed in the river , and the tiddler enjoyed splashing in the shoal there .
N. fowleriinfections are often acquired by young boys jumping into freshwater bodies.
Most in all probability , that ’s where he encountered the amoeba , which Conrad and his squad now had to kill — before it could wreak more mayhem than the tyke could survive .
PAM killing by massive destruction of brain tissue . The ameba itself does some of the destruction now , give it the " brain - eating " moniker , but much of the head damage is actually induce by the body ’s aggressive immune reply to an intruder in the ascendency arrangement , Conrad explain . Parasites that evolve to live inside a trunk usually have way of tamping down their host ’s immune reply so they do n’t lose their meal tag , Conrad said . But becauseN. fowlerihas no need for a legion , it has none of those adaptations . " It ’s a dogshit in a china shop , " Conrad enjoin .
Fortunately , there are only between zero and sixN. fowleriinfections in the U.S. each year , and there is no evidence that contagion are becoming more common , saidDr . Julia Haston , a aesculapian epidemiologist with the CDC ’s Waterborne Disease Prevention Branch . Although most cases pass off in Texas , Florida and other Southern state , there have beenmore lawsuit than common in the northerly U.S.in recent year , perhaps becauseclimate changeis warming waterways to the temperature that the amoebas favour , Haston say , anda 2021 studyfound case increase in the Midwest as far northward as Minnesota .
A microscopic image of amoebic meningoencephalitis caused byN. fowleri.
" The dependable coming for the great unwashed wondering whether they ’re at peril … is just to assume thatNaegleria fowleriamoebae are in all fresh pee , " Haston said . " Lakes , rivers , any course occurring fresh water body . "
A Hail Mary works
To battle the amoeba that was attacking the San Antonio patient ’s brain , Conrad and his team pull out a then - novel treatment , miltefosine . The drug , an antimicrobial originally used to treat leishmaniasis , an illness triggered by a tropical parasite — had shown promise againstN.fowleriin studies , so the CDC had beendistributing it for PAM cases . Miltefosine click the blood - brain barrier and is relatively well tolerated by patients , Ortiz said . That ’s authoritative , as many antiparasitic drug also damage human cells , he tote up .
The doc ordered the drug from the CDC . ( Today , it ’s useable commercially under the brand name Impavido . ) It arrived 14 hours after the tiddler was admitted .
The child lived .
But he was not unscarred . When the son go away the hospital , he could emit on his own but not do much else . After months of reclamation , he retrieve some of his ability , but his family still had to assist him with canonic self - care , Conrad say .
That same summer , however , a 13 - twelvemonth - old girl in Arkansas get the amoeba while float in an artificial pond . She received quick treatment , include miltefosine , and recovered . After six months of rehab , she had no lingering neurologic effects from this brush with last , according to a2015 case report describing her treatment .
She and the Texas boy were the first U.S. survivors of PAM since 1978 . In 2016 , a 16 - year - honest-to-goodness boy in Florida compress PAM and received miltefosine ; he alsorecovered in full .
However , not all PAM patient who have receive miltefosine have survived . Even with the new drug , PAM has a fatality rate of over 97%,according to the CDC .
Each summer , a handful of new PAM cases drink down up around the state , and physician are continually working to improve their treatment . They ’re increasingly exploring strategies like cooling patients ' body temperature to around 95 F ( 35 cytosine ) , Conrad said , which some studies suggestmight improve recoveryfrom mastermind trauma .
There may be new pharmaceuticals on the celestial horizon , too . Miltefosine can have toxic side effects on the kidneys and liver and is n’t usable in developing nation , saidJacob Lorenzo - Morales , a fourth-year lecturer in parasitology and the director of the University of La Laguna Institute of Tropical Diseases and Public Health of the Canary Islands .
So Lorenzo - Morales and his squad are looking for option . One of the most promising is nitroxoline , an antibiotic drug used in Europe to treat urinary parcel of land infections . Lorenzo - Morales and his team reported in the journalAntibioticsin August 2023 that in lab dish , low concentrations of nitroxoline induced cell expiry inN. fowleri , without make toxic essence on innkeeper cellular phone . This drug has also been used to successfully handle one patient infect witha different brain - use up amoeba , Balamuthia mandrillaris .
Now , they ’re conducting animate being study and go for to present electropositive results at next year ’s international Free - Living Amoebae Meeting , a biannual encounter of amoeba researchers . Nitroxoline is already widely available worldwide , Lorenzo - Morales said , and because it is already approved for use , extensive clinical trials wo n’t be necessary ; doctors can commence using the medication off - label .
New alternatives
There are also efforts to find new medications that work against PAM . Some researcher are concerned in developing mRNA vaccinum againstN. fowleriinfection , with a 2024 study in the journalScientific Reportsusing modeling of the amoeba ’s surface feature film to suggest what such a vaccine might look like . ( The authors of that study did not answer to requests for an consultation with Live Science . )
Lorenzo - Morales and his workfellow are also investigating the effects of a pigment called elatol , which is extracted from red alga . " We have isolated some key compounds from red algae that are very active against unlike free - sustenance amoebas , includingNaegleria , at concentrations that are even lower than the current treatments , " he said .
However , the research worker are currently doing those tests in science laboratory smasher . move examination to people will take funding from pharmaceutic companies . That can be difficult , Lorenzo - Morales order , because companies do n’t see a lot of potential for profit from a " uncommon " disease like PAM . However , he said , PAM still goes unrecognized far too often , he said , which may mean the possible market place is bigger than pharmaceutical executives believe .
A race against time
Perhaps the most immediate hope for today ’s patient is merely recognizing the disease quicker . The time to carry through someone with PAM is scant , saidJulia Walochnik , a professor of tropical medication at the Medical University of Vienna who studies amoebic diseases . " If it ’s too former , it does n’t matter which drug is used ; the affected role will ordinarily not survive , " she told Live Science .
The former onset of discussion might be one reason why Conrad ’s 8 - year - sometime patient sustained such serious brain hurt while the other youth treated around the same time recovered more full .
— ' Brain - eating ' infections could become more unwashed , scientists warn
— 7 chilling diseases you may get from the water
— Can you get a brain - eating amoeba from hydrant water ?
— This is what it ’s like to care for a ' brain - feeding ' amoeba contagion
The exam for the amoeba is simple : Take a sample of the fluid surround the learning ability and spinal electric cord and look for swimming single - celled organisms . But doctors may not call up to govern the run in clip , because PAM look like meningitis because of much more usual viruses and bacteria . Families of children who have died of the disease are more and more puzzle out to kindle sentience , which could hopefully goad immediate diagnosing and treatment . For instance , theJordan Smelski Foundation for Amoeba Awareness , start by the parent of an 11 - year - sure-enough boy who decease of PAM in 2014 , host educational events for doctors and the public .
sentience is make a remainder , Lorenzo - Morales say . " Every time we have been involved in a clinical case in the last four to five year , the diagnosis has been dissipated , " he say . " That did n’t come about before . "
